Humacyte HUMA
NASDAQ HUMA
$0.52 +0.02 (+4.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Humacyte (HUMA) Non Operating Investment Income (2020 - 2021)

Updated

Humacyte (HUMA) reported Non Operating Investment Income of $12.00 for Q2 2021, down 36.8% from the prior quarter.

Analysis

Humacyte (HUMA) Non Operating Investment Income (2020 - 2021) Analysis & Trends

For FY2020, Humacyte posted Non Operating Investment Income of $16,191.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Humacyte 144.46 Mn 144.46 Mn -825,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 12.00
Mar 31, 2021 19.00
Sep 30, 2020 -22,177.00
API Access

Humacyte Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=HUMA&period=max&api_key=YOUR_API_KEY